Coursera Flash Sale
40% Off Coursera Plus for 3 Months!
Grab it
Explore how next-generation sequencing (NGS) and synthetic DNA technologies are revolutionizing oncology research through this comprehensive webinar presented by Dr. James Flynn, a biotechnology product leader at Twist Bioscience. Discover the latest advances in customizable genomic solutions that enable earlier cancer detection, more accurate biomarker discovery, and sensitive monitoring of disease progression. Learn about DNA/RNA panels, cfDNA/cfRNA liquid biopsy workflows, and innovative methylation detection systems that support research across the entire oncology journey. Examine real-world case studies in pediatric cancer profiling, colorectal cancer screening, and minimal residual disease detection to understand how scalable, cost-effective, and high-performance NGS tools can accelerate discoveries and advance precision oncology. Gain insights into target enrichment solutions, multi-omic capabilities, custom assays, and partnerships with emerging sequencing technologies including Element's AVITI platform with Trinity Sequencing. Understand how these genomic technologies support both clinical applications and translational research, including applications in agricultural biotechnology initiatives and plasma-based clinical diagnostics for infectious disease detection.
